Bellicum Pharmaceuticals

Corium

Corium, Inc. is a commercial-stage biopharmaceutical company that is leading the development and commercialization of novel central nervous system CNS therapies that provide clinicians with important new treatment options for patients, their families, and their caregivers.

Select Venture Capital & Financial Partners

Gurnet Point Capital
www.corium.com